Chemical Research and Development, Pfizer Global Research and Development, Groton, Connecticut 06340, United States.
Anal Chem. 2011 Nov 15;83(22):8766-71. doi: 10.1021/ac202287y. Epub 2011 Oct 20.
Quantitative NMR spectrometry (qNMR) is an attractive, viable alternative to traditional chromatographic techniques. It is a fast, easy, accurate, and nondestructive technique which allows an analyst to gain quantitative information about a component mixture without the necessity of authentic reference materials, as is the case with most other analytical techniques. This is ideal for the synthesis of active pharmaceutical ingredients (API) that are in the early stages of development where authentic standards of the analytes may not be available. In this paper, the application of (19)F and (1)H qNMR for reaction monitoring and in situ potency determinations will be discussed for an early stage pharmaceutical candidate with several analytical challenges. These challenges include low UV absorption, low ionization, thermal instability, and lack of authentic reference standards. Quantitative NMR provided quick, fit-for-purpose solutions for process development where conventional separation techniques were limited.
定量核磁共振光谱(qNMR)是一种有吸引力的、可行的替代传统色谱技术的方法。它是一种快速、简单、准确且无损的技术,允许分析人员在不需要真实参考物质的情况下获得有关成分混合物的定量信息,这与大多数其他分析技术的情况相同。对于处于早期开发阶段的活性药物成分(API)的合成来说,这是理想的选择,因为在这种情况下,可能无法获得分析物的真实标准品。本文将讨论(19)F 和(1)H qNMR 在反应监测和原位效价测定中的应用,该方法适用于具有多个分析挑战的早期制药候选物。这些挑战包括低紫外吸收、低电离、热不稳定性以及缺乏真实参考标准。在常规分离技术受到限制的情况下,定量 NMR 为工艺开发提供了快速、满足目的的解决方案。